Harmon W E
Division of Nephrology, Children's Hospital, Boston, Massachusetts 02115.
Pediatr Nephrol. 1991 Jan;5(1):118-25. doi: 10.1007/BF00852868.
Opportunistic infections following renal transplantation in children are a major cause of severe morbidity and mortality. These infections account for the majority of early post renal-transplant deaths in children. General risk factors which affect the incidence and severity of these infections include: transmission of the infectious agent by the donor organ; history of immunity in the recipient prior to transplantation; type and amount of immunosuppression including treatment for rejection episodes; availability of specific treatment for the infection. Children are at particular risk because of the lack of exposure to certain pathogens prior to transplantation. There have been recent advances in the prevention and treatment of important infections which occur in children following transplantation, including varicella, Pneumocystis carinii pneumonia (PCP) and cytomegalovirus (CMV) disease. Varicella is treatable with acyclovir, often without decreasing immunosuppression and placing the graft at risk. Prophylaxis against PCP may be achieved by provision of alternate-day trimethoprim sulpha, but clear guidelines for determining who should be treated are lacking. Treatment of this disease with high-dose trimethoprim sulfa or pentamidine is usually successful. CMV disease is frequently severe, especially when the donor is seropositive and the recipient seronegative. In these situations, prophylactic CMV immunoglobulin reduces the morbidity and the mortality of the disease and prophylactic oral acyclovir may decrease its incidence. Treatment of severe CMV disease with gancyclovir is promising.
儿童肾移植后的机会性感染是严重发病和死亡的主要原因。这些感染占儿童肾移植后早期死亡的大多数。影响这些感染发生率和严重程度的一般危险因素包括:供体器官传播感染病原体;移植前受者的免疫史;免疫抑制的类型和剂量,包括抗排斥反应的治疗;针对感染的特异性治疗的可用性。由于移植前未接触某些病原体,儿童尤其容易感染。最近在预防和治疗儿童移植后发生的重要感染方面取得了进展,包括水痘、卡氏肺孢子虫肺炎(PCP)和巨细胞病毒(CMV)疾病。水痘可用阿昔洛韦治疗,通常无需降低免疫抑制水平和使移植物处于危险之中。通过隔日给予甲氧苄啶磺胺可预防PCP,但缺乏确定谁应接受治疗的明确指南。用高剂量甲氧苄啶磺胺或喷他脒治疗这种疾病通常是成功的。CMV疾病通常很严重,尤其是当供体血清学阳性而受者血清学阴性时。在这些情况下,预防性使用CMV免疫球蛋白可降低该疾病的发病率和死亡率,预防性口服阿昔洛韦可能会降低其发生率。用更昔洛韦治疗严重CMV疾病很有前景。